Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Amino Acids|October 12, 2011
Transglutaminases and receptor tyrosine kinasesManaswini Sivaramakrishnan, Gary K Shooter, Zee Upton, et al.Scientific Reports|March 23, 2017
PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemiaKim Parker, Antonio Berretta, Stefanie Saenger, et al.Biochimica Et Biophysica Acta|June 27, 2013
PEGylation of lysine residues reduces the pro-migratory activity of IGF-IManaswini Sivaramakrishnan, Abhishek S Kashyap, Beat Amrein, et al.IUBMB Life|September 14, 2013
Vitronectin--master controller or micromanager?David I Leavesley, Abhishek S Kashyap, Tristan Croll, et al.Biochimica Et Biophysica Acta|September 17, 2013
Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signallingManaswini Sivaramakrishnan, Tristan I Croll, Rajesh Gupta, et al.Biochemical and Biophysical Research Communications|January 27, 2009
Flagella-generated forces reveal gear-type motor in single cells of the green alga, Chlamydomonas reinhardtiiJacinta S D'Souza, Mohanram Gudipati, Jayashree A Dharmadhikari, et al.Human Molecular Genetics|March 7, 2013
Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 functionMeagan R Pitcher, Christopher S Ward, E Melissa Arvide, et al.Molecular Cancer Therapeutics|May 20, 2016
Antagonists of IGF:Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell FunctionsAbhishek S Kashyap, Gary K Shooter, Ali Shokoohmand, et al.Nature Communications|November 15, 2017
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiersManaswini Sivaramakrishnan, Kathleen D McCarthy, Sébastien Campagne, et al.Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.Pageof 1